Delivery Order SPE2DB22D3501-SPE2DB24FWA08
Award Date
6/18/24
Potential Completion Date
6/20/24
Potential Value
$5.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Gilenya 0.5 mg capsule 30s, with a ceiling value of $48,930.98 and a completion date of June 9, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Gilenya 0.5 mg capsules. The fixed-price contract has a ceiling value of $16,277.28 and a period of performance through May 12, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gilenya 0.5 mg capsules, a medication used to treat multiple sclerosis. The contract has a ceiling value of $42,554.38 and a period of performance through June 30, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $26,448.92 contract is for the supply of Gilenya 0.5 mg capsules, a specialty pharmaceutical product. The delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gilenya 0.5 MG Capsule 30S, a pharmaceutical product. The contract has a firm fixed price of $9,345.29 and a completion date of May 21, 2025. There is no set-aside designation for this contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Gilenya 0.5 mg capsules. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $9,992.34 and a period of performance through November 8, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $18,285.62 firm fixed-price contract is for the supply of Gilenya 0.5 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support...
This federal contract award is for the delivery of Gilenya 0.5 mg capsules to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $4,674.72. The contract is a firm-fixed price delivery order with an ultimate completion date of April 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This is a delivery order award to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. federal government. The contract, valued at $16,058.77, is for the supply of Gilenya 0.5 mg capsules to support the Defense Logistics Agency (DLA) Troop Support Medical. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a range of essential medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $45,359.88 firm-fixed-price contract is for the delivery of Gilenya 0.5 mg capsules, a prescription medication. The award has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical for providing a comprehensive range of medical...